News
A breakthrough in our understanding of mRNA delivery systems in the body may allow for more direct treatments for ...
A nationwide Danish cohort study demonstrated no increased risk of serious adverse events following vaccination with JN.1-updated mRNA COVID-19 vaccines, reinforcing their safety profile and ...
The results suggest the possibility of a vaccine for HIV/AIDS, which killed more than half a million people last year.
StockStory.org on MSN18h
Moderna Earnings: What To Look For From MRNABiotechnology company Moderna (NASDAQ:MRNA) will be reporting results this Friday before the bell. Here’s what to expect.
An mRNA cancer vaccine triggered strong immune responses and improved treatment outcomes in mice, offering a new approach to ...
The company last reported total revenues of $108M in Q1, down 35.3% Y/Y due to lower net product sales, particularly its ...
3h
New Scientist on MSNAgeing in the brain may be caused by a breakdown in protein productionThe discovery that brain ageing may be driven by jammed-up protein factories could lead to better ways to help us stay sharp ...
Biotech giant Moderna announced it will lay off 10% of its workforce in a move CEO Stéphane Bancel called “a difficult ...
Analysts have given Moderna a total of 6 ratings, with the consensus rating being Neutral. The average one-year price target ...
CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...
The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies find ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results